Drug comparisons
Bexagliflozin vs Vildagliptin
Bexagliflozin vs Vildagliptin: SGLT2 vs DPP-4 inhibitors for T2D. Compare efficacy, CV benefits, side effects & which oral drug may be better for you.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when choosing between an SGLT2 inhibitor and a DPP-4 inhibitor for type 2 diabetes patients with or without cardiovascular or renal disease.
Bottom line
Neither is universally superior; Bexagliflozin offers extra organ protection while Vildagliptin provides reliable, well-tolerated glycemic control.
All medication comparisons